Dana Investment Advisors Inc. purchased a new stake in Insmed Incorporated (NASDAQ:INSM – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 15,365 shares of the biopharmaceutical company’s stock, valued at approximately $388,000. Other hedge funds also recently made changes to their positions […]
Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have received an average recommendation of “Buy” from the nine analysts that are presently covering the company, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued ratings on the […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report) VP Michael Alexander Smith sold 627 shares of the stock in a transaction on Friday, January 5th. The shares were sold at an average price of $29.30, for a total value of $18,371.10. Following the completion of the sale, the vice president now owns 88,737 shares of the […]
StockNews.com lowered shares of Insmed (NASDAQ:INSM – Get Rating) from a hold rating to a sell rating in a research note published on Thursday morning. A number of other equities research analysts have also recently commented on INSM. Barclays dropped their target price on Insmed from $37.00 to $35.00 and set an overweight rating on […]